Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H(May 1991).“Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src”.Nature351(6321): 69–72.Bibcode:1991Natur.351...69N.doi:10.1038/351069a0.PMID1709258.
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL(January 1987).“Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene”.Science235(4785): 177–82.Bibcode:1987Sci...235..177S.doi:10.1126/science.3798106.PMID3798106.
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A(May 1989).“Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer”.Science244(4905): 707–12.Bibcode:1989Sci...244..707S.doi:10.1126/science.2470152.PMID2470152.
Lee J, Wang Z, Luoh SM, Wood WI, Scadden DT(January 1994).“Cloning of FRK, a novel human intracellular SRC-like tyrosine kinase-encoding gene”.Gene138(1–2): 247–51.doi:10.1016/0378-1119(94)90817-6.PMID7510261.
Oberg-Welsh C, Welsh M(January 1995).“Cloning of BSK, a murine FRK homologue with a specific pattern of tissue distribution”.Gene152(2): 239–42.doi:10.1016/0378-1119(94)00718-8.PMID7835707.
Thuveson M, Albrecht D, Zürcher G, Andres AC, Ziemiecki A(April 1995).“iyk, a novel intracellular protein tyrosine kinase differentially expressed in the mouse mammary gland and intestine”.Biochem. Biophys. Res. Commun.209(2): 582–9.doi:10.1006/bbrc.1995.1540.PMID7733928.
Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H(May 1991).“Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src”.Nature351(6321): 69–72.Bibcode:1991Natur.351...69N.doi:10.1038/351069a0.PMID1709258.
Dehm SM, Bonham K(April 2004).“SRC gene expression in human cancer: the role of transcriptional activation”.Biochem. Cell Biol.82(2): 263–74.doi:10.1139/o03-077.PMID15060621.
Aligayer H, Boyd DD, Heiss MM, Abdalla EK, Curley SA, Gallick GE(January 2002).“Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis”.Cancer94(2): 344–51.doi:10.1002/cncr.10221.PMID11900220.
Verbeek BS, Vroom TM, Adriaansen-Slot SS, Ottenhoff-Kalff AE, Geertzema JG, Hennipman A, Rijksen G(December 1996).“c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis”.J. Pathol.180(4): 383–8.doi:10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N.PMID9014858.
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL(January 1987).“Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene”.Science235(4785): 177–82.Bibcode:1987Sci...235..177S.doi:10.1126/science.3798106.PMID3798106.
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A(May 1989).“Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer”.Science244(4905): 707–12.Bibcode:1989Sci...244..707S.doi:10.1126/science.2470152.PMID2470152.
Nam S, Kim D, Cheng JQ, Zhang S, Lee JH, Buettner R, Mirosevich J, Lee FY, Jove R(October 2005).“Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells”.Cancer Res.65(20): 9185–9.doi:10.1158/0008-5472.CAN-05-1731.PMID16230377.
Musumeci F, Schenone S, Brullo C, Botta M(April 2012).“An update on dual Src/Abl inhibitors”.Future Med Chem4(6): 799–822.doi:10.4155/fmc.12.29.PMID22530642.
Cance WG, Craven RJ, Bergman M, Xu L, Alitalo K, Liu ET(December 1994).“Rak, a novel nuclear tyrosine kinase expressed in epithelial cells”.Cell Growth Differ.5(12): 1347–55.PMID7696183.
Lee J, Wang Z, Luoh SM, Wood WI, Scadden DT(January 1994).“Cloning of FRK, a novel human intracellular SRC-like tyrosine kinase-encoding gene”.Gene138(1–2): 247–51.doi:10.1016/0378-1119(94)90817-6.PMID7510261.
Oberg-Welsh C, Welsh M(January 1995).“Cloning of BSK, a murine FRK homologue with a specific pattern of tissue distribution”.Gene152(2): 239–42.doi:10.1016/0378-1119(94)00718-8.PMID7835707.
Thuveson M, Albrecht D, Zürcher G, Andres AC, Ziemiecki A(April 1995).“iyk, a novel intracellular protein tyrosine kinase differentially expressed in the mouse mammary gland and intestine”.Biochem. Biophys. Res. Commun.209(2): 582–9.doi:10.1006/bbrc.1995.1540.PMID7733928.
Okada M, Nakagawa H(December 1989).“A protein tyrosine kinase involved in regulation of pp60c-src function”.J. Biol. Chem.264(35): 20886–93.PMID2480346.
Nada S, Okada M, MacAuley A, Cooper JA, Nakagawa H(May 1991).“Cloning of a complementary DNA for a protein-tyrosine kinase that specifically phosphorylates a negative regulatory site of p60c-src”.Nature351(6321): 69–72.Bibcode:1991Natur.351...69N.doi:10.1038/351069a0.PMID1709258.
Dehm SM, Bonham K(April 2004).“SRC gene expression in human cancer: the role of transcriptional activation”.Biochem. Cell Biol.82(2): 263–74.doi:10.1139/o03-077.PMID15060621.
Aligayer H, Boyd DD, Heiss MM, Abdalla EK, Curley SA, Gallick GE(January 2002).“Activation of Src kinase in primary colorectal carcinoma: an indicator of poor clinical prognosis”.Cancer94(2): 344–51.doi:10.1002/cncr.10221.PMID11900220.
Ottenhoff-Kalff AE, Rijksen G, van Beurden EA, Hennipman A, Michels AA, Staal GE(September 1992).“Characterization of protein tyrosine kinases from human breast cancer: involvement of the c-src oncogene product”.Cancer Res.52(17): 4773–8.PMID1380891.
Verbeek BS, Vroom TM, Adriaansen-Slot SS, Ottenhoff-Kalff AE, Geertzema JG, Hennipman A, Rijksen G(December 1996).“c-Src protein expression is increased in human breast cancer. An immunohistochemical and biochemical analysis”.J. Pathol.180(4): 383–8.doi:10.1002/(SICI)1096-9896(199612)180:4<383::AID-PATH686>3.0.CO;2-N.PMID9014858.
Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL(January 1987).“Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene”.Science235(4785): 177–82.Bibcode:1987Sci...235..177S.doi:10.1126/science.3798106.PMID3798106.
Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, Levin WJ, Stuart SG, Udove J, Ullrich A(May 1989).“Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer”.Science244(4905): 707–12.Bibcode:1989Sci...244..707S.doi:10.1126/science.2470152.PMID2470152.
Nam S, Kim D, Cheng JQ, Zhang S, Lee JH, Buettner R, Mirosevich J, Lee FY, Jove R(October 2005).“Action of the Src family kinase inhibitor, dasatinib (BMS-354825), on human prostate cancer cells”.Cancer Res.65(20): 9185–9.doi:10.1158/0008-5472.CAN-05-1731.PMID16230377.
Musumeci F, Schenone S, Brullo C, Botta M(April 2012).“An update on dual Src/Abl inhibitors”.Future Med Chem4(6): 799–822.doi:10.4155/fmc.12.29.PMID22530642.